Curriculum Vitaes
Profile Information
- Affiliation
- Senior Assistant Professor, School of Medical Sciences, Faculty of Medical Technology, Fujita Health University
- Degree
- 医学博士(藤田保健衛生大学)
- Researcher number
- 20569701
- J-GLOBAL ID
- 201801012069684307
- researchmap Member ID
- 7000023878
Research Interests
9Research Areas
4Research History
6-
Apr, 2023 - Present
-
Apr, 2017 - Present
-
Oct, 2018 - Aug, 2021
-
Apr, 2017 - Oct, 2018
Education
2-
Apr, 2007 - Mar, 2009
-
Apr, 2004 - Mar, 2007
Awards
4Papers
37-
Emerging Infectious Diseases, 30(12), Dec, 2024
-
Journal of medical virology, 96(8) e29847, Aug, 2024 Peer-reviewedLead authorCorresponding authorTo elucidate the seroprevalence and rate of asymptomatic infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Japanese children, serological analysis was performed using serum samples collected from March 2020 to February 2023. A total of 1493 serum samples were collected during the first study period (March 2020 to February 2021). None of the serum samples was positive for SARS-CoV-2 antibody. In the second period (March 2021 to February 2022), seven of the 1055 patients (0.7%) experienced SARS-CoV-2 infection. The third period (March 2022 to February 2023) was divided into three terms: from March to June 30, 2022; from July to October 2022; and from November 2022 to February 2023. The seroprevalence gradually increased throughout this period, with rates of 6.0%, 18.6%, and 30.4% in the three terms, respectively. Pediatric cases of asymptomatic SARS-CoV-2 infection occurred after the surge of Omicron variants. Since none of the SARS-CoV-2 antibody-positive patients had a previous history of coronavirus disease 2019, the seroprevalence rate in this study may represent the rate of asymptomatic infection.
-
Viruses, 16(8), Jul 25, 2024 Peer-reviewedThe live attenuated human rotavirus vaccine strain RIX4414 (Rotarix®) is used worldwide to prevent severe rotavirus-induced diarrhea in infants. This strain was attenuated through the cell culture passaging of its predecessor, human strain 89-12, which resulted in multiple genomic mutations. However, the specific molecular reasons underlying its attenuation have remained elusive, primarily due to the absence of a suitable reverse genetics system enabling precise genetic manipulations. Therefore, we first completed the sequencing of its genome and then developed a reverse genetics system for the authentic RIX4414 virus. Our experimental results demonstrate that the rescued recombinant RIX4414 virus exhibits biological characteristics similar to those of the parental RIX4414 virus, both in vitro and in vivo. This novel reverse genetics system provides a powerful tool for investigating the molecular basis of RIX4414 attenuation and may facilitate the rational design of safer and more effective human rotavirus vaccines.
-
The Pediatric infectious disease journal, Feb 28, 2024 Peer-reviewedWe encountered a previously healthy 3-year-old girl with interstitial pneumonitis that initially developed due to human adenovirus type 2 infection and exacerbated by primary human herpesvirus 7 infection. A comprehensive serum biomarker analysis showed patterns that differed by viral infection, suggesting that respiratory and lymphotropic viral infections might have different pathophysiology in interstitial pneumonitis.
Misc.
78-
INFECTION CONTROL, 32(5) 460-464, May, 2023
-
Fujita medical journal, 9(2) 90-94, May, 2023Objectives: Fetal human cytomegalovirus (HCMV) infection might be involved in fetal growth restriction (FGR). Maternal serostatus and the prevalence of congenital HCMV infection are affected by various factors, such as socioeconomic status and ethnicity. Therefore, the prevalence of congenital HCMV-related FGR should be examined in each region. Methods: Seventy-eight cases of FGR with delivery between January 2012 and January 2017 at Fujita Health University Hospital were studied. Twenty-one non-FGR cases were also included as a control group. Placental sections obtained from the FGR and control cases were immunostained with two primary antibodies for detecting immediate early antigens. Results: Nineteen placental samples from FGR cases with another etiology were excluded. Finally, 59 placental samples from FGR cases of unknown etiology were included in the pathological analysis. Four of 59 (6.8%) placental samples were positive for HCMV antigen. All four positive cases were stained with the M0854 antibody, and cases showed positivity for the MAB 810R antibody. Neither maternal nor infantile clinical features were different between the HCMV-positive and -negative FGR cases. A pathological examination showed a hematoma in three of four cases and infarction in two of four cases. Conclusions: HCMV antigen was detected in 6.8% of placental samples obtained from FGR cases without an obvious etiology. No remarkable maternal or neonatal clinical features discriminated HCMV-related FGR from FGR due to other causes. Vasculitis and inflammation might play important roles in the pathogenesis of HCMV-related FGR.
-
医療検査と自動化, 48(1) 75-80, Feb, 2023厚生労働省より承認された重症急性呼吸器症候群コロナウイルス-2(SARS-CoV-2)抗原検査キットのうち6種の性能比較を行った。その結果,1キットのみが突出した検出感度を有していることが観察されRT-PCRのCt値28.0までの検体が検出可能であった。それ以外はほぼ同等の結果であり,Ct値25.0の検体の検出が16.7~100%で可能であった。SARS-CoV-2抗原検査キットは検出感度に若干の差異があるため,導入にあたっては検査キットの性能特性や操作性を踏まえて選定する必要がある。(著者抄録)
-
臨床とウイルス, 50(4) 217-222, Oct, 2022
-
臨床とウイルス, 50(1) 25-29, Mar, 2022
-
医学と薬学, 79(3) 383-390, Feb, 2022
-
日本ウイルス学会学術集会プログラム・予稿集(Web), 68th, 2021
-
臨床とウイルス, 46(4) 313-323, Oct, 2018RV5は、ウシロタウイルスを基盤とし、異なるヒトロタウイルス遺伝子を含む5種類の組換えウイルスからなる弱毒生ワクチンであり、RV5接種後は便中にRVワクチン株が長期間排泄されるが、体内でこれら5種類の遺伝子型がどのように増殖し排泄されるのかは不明である。そこで、5種類のG遺伝子型特異的real-time RT-PCRを構築し、RV5接種児8例で便中排泄を解析した。接種回数を重ねるごとに便中RV排泄量は減少し、5つのG遺伝子型の排泄パターン様々であったが、G1遺伝子型とG6遺伝子型が他の遺伝子型に比べて多く排出されていた。
Books and Other Publications
3Teaching Experience
10Professional Memberships
6Research Projects
12-
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Apr, 2024 - Mar, 2029
-
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Apr, 2022 - Mar, 2025
-
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Apr, 2021 - Mar, 2024
-
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Apr, 2021 - Mar, 2024
-
Grants-in-Aid for Scientific Research Grant-in-Aid for Early-Career Scientists, Japan Society for the Promotion of Science, Apr, 2020 - Mar, 2022